A mutation in the human canalicular multispecific organic anion transporter gene causes the Dubin-Johnson syndrome

Hepatology : Official Journal of the American Association for the Study of Liver Diseases
C C PaulusmaR P Oude Elferink

Abstract

The human Dubin-Johnson syndrome (DJS) is a rare autosomal recessive liver disorder characterized by chronic conjugated hyperbilirubinemia. Patients have impaired hepatobiliary transport of non-bile salt organic anions. A highly similar phenotype has been described for a mutant Wistar rat strain, the transport-deficient (TR-) rat, which is defective in the canalicular multispecific organic anion transporter (cmoat). This protein mediates adenosine triphosphate-dependent transport of a broad range of endogenous and xenobiotic compounds across the (apical) canalicular membrane of the hepatocyte. The complementary DNA (cDNA) encoding rat cmoat has recently been cloned, and the mutation underlying the defect in TR- rats has been identified. In the present study, we have isolated the human homologue of rat cmoat, human cMOAT, and analyzed the corresponding cDNA from fibroblasts of a DJS patient for mutations. Our results show that a mutation in this gene is the cause of DJS.

Citations

Mar 31, 1999·Journal of Biochemical and Molecular Toxicology·E G Schuetz, A H Schinkel
Oct 31, 1998·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·L HuangM Vore
Aug 29, 2007·Journal of Physiology and Biochemistry·R P J Oude Elferink, R de Waart
Sep 29, 2006·Rheumatology International·Cengiz Korkmaz, Timuçin Kaşifoğlu
Jan 22, 1998·Mammalian Genome : Official Journal of the International Mammalian Genome Society·F LammertD R Beier
Jul 19, 2006·Pflügers Archiv : European journal of physiology·Anne T Nies, Dietrich Keppler
Aug 29, 2006·Wiener medizinische Wochenschrift·Gernot Zollner, Michael Trauner
Mar 26, 1998·Journal of Hepatology·M Müller, P L Jansen
Mar 30, 2005·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Olivier FardelLea Payen
Jan 7, 2004·European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences·Lauretta M S ChanBarry H Hirst
Jun 1, 2005·Journal of Hepatology·Huey-Ling ChenMei-Hwei Chang
Jun 25, 2005·Journal of Hepatology·Christiane Pauli-MagnusPeter J Meier
Sep 16, 2000·European Journal of Pharmacology·R A Van AubelF G Russel
Sep 8, 2001·Steroids·K AkimotoH Takikawa
Jan 5, 2002·Journal of Controlled Release : Official Journal of the Controlled Release Society·Hiroyuki Kusuhara, Yuichi Sugiyama
Mar 23, 2000·Journal of Hepatology·G A Kullak-UblickG Paumgartner
Sep 17, 1999·Journal of Hepatology·G A Kullak-Ublick
Jul 29, 1999·Journal of Hepatology·M TraunerJ L Boyer
Dec 31, 2002·Toxicology·Richard B Kim
Jul 14, 1999·Toxicology Letters·P ZimniakY C Awasthi
Nov 24, 1999·Free Radical Biology & Medicine·D Keppler
Sep 28, 1998·Biochimica Et Biophysica Acta·T IyanagiS Ikushiro
Dec 21, 2000·European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences·G J HooiveldM Müller
Aug 28, 1998·Current Opinion in Cell Biology·B Stieger, P J Meier
May 29, 2000·Current Opinion in Genetics & Development·R Thompson, S Strautnieks
Mar 6, 2004·Seminars in Neonatology : SN·Eve A Roberts
May 6, 2003·Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy·Alex SparreboomWilliam D Figg
Mar 29, 2008·Expert Reviews in Molecular Medicine·Marco ArreseJose J G Marin
Nov 13, 2008·Cytotechnology·I Bosch, J M Croop

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.